Journals

Yin Y, Jiang Y, Lam KG, Berletch JB, Disteche CM, Noble WS, Steemers FJ, Camerini-Otero RD, Adey AC, Shendure JA. “High-Throughput Single-Cell Sequencing with Linear Amplification” Molecular Cell, 2019.

Works M, Soni N, Hauskins C, Sierra C, Baturevych A, Jones JC, Curtis W, Carlson P, Johnstone TG, Kugler D, Hause RJ, Jiang Y, Wimberly L, Clouser CR, Jessup HK, Sather B, Salmon RA, Ports MO. “Anti-B-cell maturation antigen chimeric antigen receptor T cell function against multiple myeloma is enhanced in the presence of lenalidomide” Molecular Cancer Therapeutics, 2019.

Ibarra-Soria X, Nakahara TS, Lilue J, Jiang Y, Trimmer C, Souza MA, Netto PH, Ikegami K, Murphy NR, Kusma M, Kirton A, Saraiva LR, Keane TM, Matsunami H, Mainland JD, Papes F, Logan DW. “Variation in olfactory neuron repertoires is genetically controlled and environmentally modulated.” eLife, 6: e21476, 2017.

Jiang Y, Gong N, Hu X, Ni J, Pasi R, Matsunami H. “Molecular profiling of activated olfactory neurons identifies odorant receptors for odors in vivo.” Nature Neuroscience, 18: 1446-1454, 2015.

Jiang Y*, Li Y*, Tian H, Ma M, Matsunami H. “Muscarinic acetylcholine receptor M3 modulates odorant receptor activity via inhibition of \(\beta\)-arrestin-2 recruitment.” *equal contributions. Nature Communications, 6: 6448, 2015.

Jiang Y and Matsunami H. “Mammalian odorant receptors: functional evolution and variation.” Current Opinion in Neurobiology, 34: 54-60, 2015.

Jiang Y, Dey S, Matsunami H. “Calreticulin: roles in cell-surface protein expression.” Membranes, 4: 630-641, 2014.

Jiang Y, Gong N, Matsunami H. “Astringency: a more stringent definition.” Chemical Senses, 39: 467-469, 2014.

Chen B, Jiang Y, Zeng S, Yan J, Li X, Zhang Y, Zou W, Wang X. “Endocytic sorting and recycling require membrane phosphatidylserine asymmetry maintained by TAT-1/CHAT-1.” Plos Genetics, 6: e1001235, 2010.

Conference proceedings

Larson RP, RL, Devries T, Jiang Y, Hause RJ, Getto R, Christin B, Yee NK, Bowen M, Weber C, Li D, Albertson T, Sutherland CL, Ramsborg CG. “Defined cell composition and precise control over JCAR017 dose enables identification of relationships between chimeric antigen receptor T cell product attributes, pharmacokinetics, and clinical endpoints in non-Hodgkin lymphoma.” American Association for Cancer Research (AACR) Annual Meeting, 2018.

Vong Q, Nye C, Hause RJ, Clouser C, Jones J, Burleigh S, Borges CM, Chin SY, Marco E, Barrera L, Da Silva J, Harbinski F, Giannoukos G, Dhanapal V, Jiang Y, Ruth Salmon R, Wilson CJ, Myer VE, Welstead GG, Bond CJ and Sather BD. “Inhibiting TGF\(\beta\) Signaling in CAR T-Cells May Significantly Enhance Efficacy of Tumor Immunotherapy.” American Society of Hematology (ASH) 59th Annual Meeting, 2017.

Works M, Soni N, Hauskins C, Sierra C, Baturevych A, Jones J, Curtis W, Johnstone T, Kugler D, Jiang Y, Hause RJ, Sather BD, Salmon R and Ports M. “Lenalidomide Enhances Anti-Bcma Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma.” American Society of Hematology (ASH) 59th Annual Meeting, 2017.

Chadwick E, Noll A, Jiang Y, Hause RJ, Ponce R, Levitsky H, Salmon R. “A syngeneic mouse model of CAR-T mediated toxicity and neuroinflammation.” The Society for Immunotherapy of Cancer’s (SITC) 32nd Annual Meeting, 2017.

Thomas EP, Jessup HK, Qin J, Jiang Y, Swanson C, Baturevych A, Swenson S, Prentice K, Hause RJ, Levitsky H, Ports M. “IDO1-mediated tryptophan depletion potently inhibits CAR-T functionality as part of a CAR-T driven adaptive immune resistance response in the tumor microenvironment.” The Society for Immunotherapy of Cancer’s (SITC) 32nd Annual Meeting, 2017.

Goldfless SJ, Croft A, Brandt CS, Jeffery EW, Connor KL, Clouser CR, Jiang Y, Johnstone TG, Koppstein D, Nguyen H, Peper H, Toy D, Sissons J, Hause RJ, Briggs AW, Vigneault F. “Discovery of Rare T Cell Receptors of Therapeutic Value by Simultaneous Detection of Sequence, Antigen Specificity and Cell Phenotype from Millions of Single Cells in Emulsion.” Keystone Symposia on Molecular and Cellular Biology, 2017.